Author

Shemeica Binns

Observed names: Binns, Shemeica, S. N. Binns, Shemeica N. Binns

Institution: New York Medical College

Observed institutions: University of North Carolina at Chapel Hill, Sunnybrook Health Science Centre, Mayo Clinic, Harvard University, New York Medical College, University of Toronto, Queen's University, Yale University, Massachusetts General Hospital, Fred Hutch Cancer Center, UNC Lineberger Comprehensive Cancer Center, Canadian Cancer Trials Group, Odette Cancer Centre

OpenAlex ID: A5044226702

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

2013 · Dennis C. Sgroi, Erin Carney, et al. · JNCI Journal of the National Cancer Institute · 229

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

2016 · Dennis C. Sgroi, Judy-Anne W. Chapman, et al. · Breast Cancer Research · 72

Microproteomic analysis of 10,000 laser captured microdissected breast tumor cells using short-range sodium dodecyl sulfate-polyacrylamide gel electrophoresis and porous layer open tubular liquid chromatography tandem mass spectrometry

2011 · Dipak Thakur, Tomas Rejtar, et al. · Journal of Chromatography A · 62

Case Report of Subanesthetic Intravenous Ketamine Infusion for the Treatment of Neuropathic Pain and Depression with Suicidal Features in a Pediatric Patient

2018 · Garret Weber, JuHan Yao, et al. · Case Reports in Anesthesiology · 29

Prediction of late recurrences by breast cancer index in the NCIC CTG MA.17 cohort.

2011 · D. Sgroi, E. Carney, et al. · Journal of Clinical Oncology · 3

Abstract P6-01-10: Prognostic significance of breast cancer index (BCI) in node-positive hormone receptor positive early breast cancer: NCIC CTG MA.14

2015 · Dennis Sgroi, Paul Goss, et al. · Cancer Research · 2

Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14

2016 · Judith-Anne W. Chapman, Dennis C. Sgroi, et al. · Breast Cancer Research and Treatment · 1

Additional file 2: Figure S2. of Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

2016 · Sgroi, Dennis, Judy-Anne Chapman, et al. · Figshare

Additional file 1: Figure S1. of Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

2016 · Sgroi, Dennis, Chapman, Judy-Anne, et al. · Figshare

Additional file 3: Figure S3. of Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

2016 · Sgroi, Dennis, Chapman, Judy-Anne, et al. · Figshare

Assessment of the prognostic and predictive utility of the breast cancer index (BCI): An NCIC CTG MA.14 study.

2012 · Dennis Sgroi, Paul Edward Goss, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 398

H-index: 4

I10-index: 4